![]() |
![]() |
![]() |
LEGAL NOTICE No company is allowed to promote or sell any product for use in the prevention or treatment of any disease without first filing a New Drug Application (“NDA”) and obtaining FDA drug approval for the given product (drug) for the particular disease use. Any information presented by Argentech, Inc., (the “Company”) that appears to suggest that potential benefits in terms of preventing or treating disease might result from using any product it may manufacture, license and/or sell is strictly for the purpose of sharing such information with potential and existing advisors, strategic partners, grant providers, investors, government agencies, researchers and other entities. Such information should be treated with discretion by its recipients and is expressly not to be used for the promotion or sale of any product. No significant studies have been conducted to date that would determine whether any such products offer any such benefits, and there is no assurance that the Company will ever file an NDA or obtain FDA drug approval for any product. |
![]() |
| Contact: Jay Newman, President & CEO | email: jnewman@argentechinc.com | phone: (954) 486-9304 |
© 2010 Argentech, Inc., all rights reserved
Please see our Legal Notice
The statements herein have not been evaluated by the Food & Drug Administration.
No product described herein nor any information thereon is intended to diagnose, treat, cure or prevent any disease.
Silver 100™, ProSilver 240™ and Opti-Silver™ are trademarks of Invision International Health Solutions, Inc.,
the exclusive manufacturer of Silver 100™ and ProSilver 240™ with Opti-Silver™